Home Addiction recovery in Mexico Medication-Assisted Treatment (MAT): Evidence Over Stigma

Medication-Assisted Treatment (MAT): Evidence Over Stigma

Medication-assisted treatment — MAT — is one of the most evidence-supported approaches in addiction medicine, yet it remains one of the most stigmatized. Many people, families, and even some in recovery communities still hold the belief that MAT means “replacing one drug with another,” or that recovery on medication isn’t “real” recovery. The science says otherwise, clearly and consistently. For opioid and alcohol use disorders, MAT significantly improves outcomes — reducing overdose deaths, increasing treatment retention, and supporting lasting recovery — and the stigma around it costs lives.

This article explains what MAT includes, how it works for opioids and alcohol, debunks common myths, and explains why the combination of MAT and therapy produces the best outcomes. All medication decisions belong to qualified medical professionals; this article is educational, not prescriptive.

—

WHAT MAT INCLUDES

Medication-assisted treatment refers to the use of FDA-approved medications, combined with counseling and behavioral therapies, to treat substance use disorders. The “assisted” in MAT is key: medication is a tool that assists recovery, not a standalone solution and not a replacement for therapy.

MAT is most well-established for two conditions:

Opioid use disorder (OUD). A range of FDA-approved medications help people with opioid addiction maintain stability, reduce cravings, avoid illicit opioid use, and stay in treatment.
Alcohol use disorder (AUD). FDA-approved medications help reduce cravings, reduce consumption, and support abstinence.

The core components of MAT are:

FDA-approved medication, selected and dosed by qualified medical professionals based on the individual’s situation.
Counseling and behavioral therapy, providing the therapeutic work that medication alone doesn’t address — the psychological, behavioral, and social dimensions of recovery.
Ongoing medical monitoring, with medication decisions adjusted by the medical team over time.

MAT is not a shortcut or a substitute for the work of recovery; it’s a medical tool that makes recovery more accessible and sustainable by addressing the neurobiological dimension of addiction while therapy addresses the rest. The combination is what produces the best outcomes.

—

MAT FOR OPIOIDS: METHADONE, BUPRENORPHINE, NALTREXONE

For opioid use disorder, there are three main FDA-approved medications, each with a different mechanism, profile, and appropriate use. All decisions about which medication is appropriate for a given person belong entirely to qualified medical professionals.

Methadone:

A long-acting opioid agonist that activates opioid receptors, significantly reducing withdrawal symptoms and cravings without producing the euphoria of illicit opioids when used as prescribed.
Dispensed in licensed opioid treatment programs (OTPs), typically as a daily oral dose under supervision.
Highly effective for severe OUD, particularly for those who haven’t responded to other approaches, with strong evidence for reducing illicit use and overdose deaths.
Requires careful medical management and monitoring because of its long half-life and potential for interactions.

Buprenorphine (often combined with naloxone, as in Suboxone):

A partial opioid agonist that activates opioid receptors less fully than full agonists like methadone, significantly reducing withdrawal and cravings with a “ceiling effect” that limits respiratory depression risk.
Can be prescribed by certified providers and taken at home, offering more flexibility than methadone.
Highly effective and widely used, with strong evidence for reducing illicit opioid use and improving outcomes.
The naloxone component (in combination products like Suboxone) is included to deter misuse by injection.

Naltrexone (including the extended-release injection, Vivitrol):

An opioid antagonist that blocks opioid receptors, so that opioids produce no effect if taken, removing the reward of relapse.
Requires full detoxification before starting — naltrexone cannot be started while opioids are still in the system.
Available as oral tablets or as a monthly injectable (Vivitrol), with the injectable offering adherence advantages.
Works differently from the agonist medications — rather than managing withdrawal, it works after detox is complete.

These medications are not interchangeable; each is appropriate for different patients and circumstances. The selection is always a medical decision.

—

MAT FOR ALCOHOL

MAT for alcohol use disorder is less widely known than for opioids, but it’s equally evidence-supported and equally stigmatized in some quarters. FDA-approved medications for alcohol use disorder include:

Naltrexone (oral or injectable). Reduces alcohol cravings and the rewarding effects of alcohol, helping people drink less or achieve abstinence. Evidence consistently supports its effectiveness.
Acamprosate. Helps reduce the protracted withdrawal symptoms and discomfort that can drive relapse after alcohol detox, supporting abstinence.
Disulfiram (Antabuse). Creates an aversive reaction if alcohol is consumed, acting as a deterrent. Effectiveness depends significantly on adherence and is appropriate for selected, motivated patients.

As with opioid MAT, all decisions about alcohol MAT medications — which to use, how to use them, and for how long — belong to qualified medical professionals who assess the individual’s full picture.

—

COMMON MYTHS DEBUNKED

The stigma around MAT is driven largely by persistent myths. Addressing these clearly matters, because stigma is a real barrier that prevents people from accessing effective, evidence-based care.

Myth: “MAT is just replacing one drug with another.”
Reality: This misunderstands how MAT works and what addiction is. MAT medications are prescribed and monitored by physicians, used therapeutically to address the neurobiological aspects of addiction, at doses calibrated to stabilize rather than intoxicate. The difference between prescribed MAT and illicit drug use is analogous to the difference between prescribed blood pressure medication and street drugs — one is controlled, therapeutic medical treatment; the other is not. A person on MAT is not trading one addiction for another; they’re treating a medical condition.

Myth: “Recovery on MAT isn’t real recovery.”
Reality: This is a values-based claim, not a scientific one, and it’s not supported by evidence. Recovery means living a fulfilling, functional life free from the destructive patterns of addiction. If MAT helps someone achieve and sustain that — which research shows it does — it is absolutely recovery. Insisting on medication-free recovery as the only “real” recovery causes harm by driving people away from effective treatment and toward higher relapse and overdose risk.

Myth: “MAT is a crutch.”
Reality: We don’t call blood pressure medication or insulin a “crutch” for people with hypertension or diabetes. Addiction is a brain disease with biological components, and MAT addresses those components medically, just as other medications address other medical conditions. Using medication to manage a medical condition is appropriate treatment, not weakness.

Myth: “People can just stop MAT when they feel better.”
Reality: MAT duration is a medical decision based on individual need. For many people, longer-term or ongoing MAT is appropriate and significantly improves outcomes. Stopping prematurely — especially opioid MAT — carries serious relapse and overdose risk. All changes to MAT belong with the medical team.

—

WHY MAT + THERAPY = BEST OUTCOMES

The evidence is consistent: the combination of MAT and behavioral therapy produces better outcomes than either alone. This is why “medication-assisted treatment” specifies the word “assisted” — medication assists a comprehensive treatment approach that includes therapy.

Why the combination works:

MAT addresses the neurobiological dimension. Cravings, withdrawal, and the neurological adaptations of addiction are addressed medically, making it far easier to engage in therapy and daily life.
Therapy addresses everything else. The psychological drivers, behavioral patterns, coping deficits, trauma, co-occurring conditions, and social dimensions of addiction require therapeutic work that medication alone doesn’t provide.
MAT improves treatment retention. People on MAT are more likely to stay in treatment, and more time in treatment is consistently associated with better outcomes.
The combination reduces relapse and overdose. Research consistently shows that MAT combined with therapy reduces illicit drug use, overdose deaths, and transmission of infectious disease more than either approach alone.

At Oceánica, treatment for opioid and alcohol use disorders is comprehensive and individualized, with all MAT decisions made by qualified medical professionals and combined with intensive therapy — two individual and five group sessions weekly, with an 8:1 therapist-to-patient ratio and a fully English-speaking clinical team.

The evidence is not ambiguous: MAT is a valuable, evidence-based component of addiction treatment, and stigma against it costs lives. If you or someone you love is considering treatment for opioid or alcohol use disorder, know that MAT — when indicated and appropriately combined with therapy — is a legitimate, effective, and scientifically supported part of comprehensive care. Oceánica’s admissions team can answer your questions confidentially.

—

FREQUENTLY ASKED QUESTIONS

What is medication-assisted treatment (MAT)?

MAT is the use of FDA-approved medications, combined with counseling and behavioral therapies, to treat substance use disorders — primarily opioid and alcohol use disorders. Medication addresses the neurobiological dimension of addiction while therapy addresses the psychological and behavioral dimensions; the combination produces the best outcomes.

Is MAT “just replacing one drug with another”?

No. This is a common myth that misunderstands addiction and MAT. MAT medications are prescribed and monitored by physicians for therapeutic purposes, at calibrated doses, as part of comprehensive treatment. The comparison is more accurate to blood pressure medication than to illicit drug use.

Do I have to be on MAT to recover?

MAT is one evidence-based component of treatment, appropriate for some people and conditions. Recovery is not defined by being on or off medication; it’s defined by living a fulfilling, functional life free from destructive addiction patterns. For those for whom MAT is indicated, using it is appropriate treatment, not a failure.

Who decides about MAT medications?

All decisions about MAT — which medication, what dose, for how long, and any changes — belong to qualified medical professionals who assess each individual’s situation. This article is educational and does not provide medical advice or recommendations.

—

SUGGESTED INTERNAL LINKS

Opioid Addiction Treatment in Mexico
Alcohol Rehab in Mexico
Suboxone vs. Methadone: Which Is Right for You?
Services and Programs at Oceánica

EXTERNAL REFERENCE LINKS

—

Oceánica is a CARF-accredited residential treatment center in Mazatlán, Mexico, where opioid and alcohol use disorders are treated with comprehensive, individualized care — with all MAT and medication decisions made by qualified medical staff — combined with intensive therapy. This article is informational and not medical advice. Call (213) 527-3377 or visit oceanica-usa.com.